Arkema Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Arkema wird ein jährliches Gewinn- und Umsatzwachstum von 17.5% bzw. 4.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 17.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.9% betragen.

Wichtige Informationen

17.6%

Wachstumsrate der Gewinne

17.7%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	10.6%
Wachstumsrate der Einnahmen	4.5%
Zukünftige Eigenkapitalrendite	10.3%
Analystenabdeckung	Good
Zuletzt aktualisiert	27 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02

Recent updates

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Dec 30

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Dec 15

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Nov 29

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Sep 07

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Aug 20

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Aug 02

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

May 28

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

May 13

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

May 09

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Apr 24

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 05

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Feb 26

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Feb 14

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Jan 30

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Jan 14

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Nov 02

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Oct 11

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Jul 19

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Jul 04

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Jun 03

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

May 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Apr 25

Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Apr 24

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Apr 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Mar 27

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Feb 27

Is Now The Time To Put Arkema (EPA:AKE) On Your Watchlist?

Feb 15

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Feb 02

Gewinn- und Umsatzwachstumsprognosen

ENXTPA:AKE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	10,671	731	605	1,378	14
12/31/2025	10,256	653	519	1,305	15
12/31/2024	9,694	557	521	1,267	16
3/31/2024	9,331	349	570	1,214	N/A
12/31/2023	9,514	402	638	1,272	N/A
9/30/2023	9,799	393	583	1,267	N/A
6/30/2023	10,445	503	688	1,382	N/A
3/31/2023	11,187	752	805	1,489	N/A
12/31/2022	11,550	949	789	1,496	N/A
9/30/2022	11,543	1,050	656	1,347	N/A
6/30/2022	10,969	1,073	298	1,013	N/A
3/31/2022	10,180	1,498	166	914	N/A
12/31/2021	9,519	1,293	152	915	N/A
9/30/2021	9,004	1,212	193	905	N/A
6/30/2021	8,515	1,057	457	1,132	N/A
3/31/2021	8,022	350	523	1,163	N/A
12/31/2020	7,884	304	510	1,115	N/A
9/30/2020	7,952	312	680	1,288	N/A
6/30/2020	8,259	365	615	1,232	N/A
3/31/2020	8,611	422	543	1,161	N/A
12/31/2019	8,738	491	665	1,300	N/A
9/30/2019	8,892	561	596	1,247	N/A
6/30/2019	8,843	590	614	1,263	N/A
3/31/2019	8,859	633	564	1,201	N/A
12/31/2018	8,816	674	438	1,029	N/A
9/30/2018	8,566	685	433	961	N/A
6/30/2018	8,418	653	461	943	N/A
3/31/2018	8,346	594	537	1,005	N/A
12/31/2017	8,326	543	N/A	1,008	N/A
9/30/2017	8,221	492	N/A	904	N/A
6/30/2017	8,040	446	N/A	877	N/A
3/31/2017	7,794	433	N/A	833	N/A
12/31/2016	7,535	394	N/A	821	N/A
9/30/2016	7,443	390	N/A	955	N/A
6/30/2016	7,551	355	N/A	863	N/A
3/31/2016	7,705	341	N/A	885	N/A
12/31/2015	7,683	285	N/A	858	N/A
9/30/2015	7,354	263	N/A	640	N/A
6/30/2015	6,886	226	N/A	587	N/A
3/31/2015	6,300	144	N/A	481	N/A
12/31/2014	5,952	167	N/A	507	N/A
9/30/2014	5,932	161	N/A	520	N/A
6/30/2014	5,949	202	N/A	577	N/A
3/31/2014	6,058	275	N/A	523	N/A
12/31/2013	6,098	168	N/A	467	N/A
9/30/2013	6,134	192	N/A	482	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: AKEDas prognostizierte Gewinnwachstum (17.5% pro Jahr) liegt über der Sparquote (1.1%).

Ertrag vs. Markt: AKEDie Erträge des Unternehmens (17.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt French (11% pro Jahr).

Hohe Wachstumserträge: AKEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: AKEDie Einnahmen des Unternehmens (4.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (5.8% pro Jahr).

Hohe Wachstumseinnahmen: AKEDie Einnahmen des Unternehmens (4.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: AKEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.9%).

Arkema Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 20%

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%, revenue upgraded

Price target decreased to €104

Recent updates

Consensus EPS estimates fall by 11%

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of €3.50 per share

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Arkema S.A. (ENXTPA:AKE) agreed to acquire The Dow Chemical Company from Dow Inc. (NYSE:DOW) for an enterprise value of $150 million.

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Dividend increased to €3.50

Consensus EPS estimates fall by 20%

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2023 earnings: EPS misses analyst expectations

Arkema S.A. to Report Q2, 2024 Results on Aug 01, 2024

Arkema S.A. (ENXTPA:AKE) acquired an unknown minority stake in Tiamat.

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Arkema S.A. (ENXTPA:AKE) acquired Arc Bulding Products.

Arkema S.A. (ENXTPA:AKE) completed the acquisition of 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity.

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Arkema S.A. to Report Q1, 2024 Results on May 07, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Arkema S.A., Annual General Meeting, May 15, 2024

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Now 21% undervalued

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates increase by 11%

Arkema S.A. agreed to acquire Polytec PT GmbH Polymere Technologien.

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

Arkema S.A. Appoints Florence Lambert and Séverin Cabannes as Director

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

Upcoming dividend of €3.40 per share at 3.9% yield

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 11%, revenue upgraded

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Full year 2022 earnings: EPS misses analyst expectations

Arkema S.A. Announces Executive Changes

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Prayon S.A. completed the acquisition of Febex S.A from Arkema S.A. (ENXTPA:AKE).

Arkema S.A. to Report Q1, 2023 Results on May 05, 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Prayon S.A. entered into an agreement to acquire Febex S.A from Arkema S.A. (ENXTPA:AKE).

Price target decreased to €104

Price target decreased to €106

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Arkema S.A. (ENXTPA:AKE) acquired Polimeros Especiales, S.A. De C.V.

Arkema S.A. to Report Fiscal Year 2022 Results on Feb 23, 2023

Consensus EPS estimates increase by 12%

Arkema S.A. (ENXTPA:AKE) agreed to acquire Polimeros Especiales, S.A. De C.V.

Consensus EPS estimates increase by 11%

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Investor sentiment deteriorated over the past week

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Consensus EPS estimates fall by 10%

Upcoming dividend of €3.00 per share

Consensus EPS estimates increase by 28%

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's